MedTrace Logo

Treatment Outcome of Vascular Depression

NCT00045773 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 208

Last updated 2017-10-31

No results posted yet for this study

Summary

This 12-week study will evaluate the effectiveness of sertraline (Zoloft®) for treatment of depression associated with small vascular lesions in the brain (vascular depression).

Conditions

Interventions

DRUG

Sertraline

50 - 200mg, once per day for 12 weeks.

Sponsors & Collaborators

Principal Investigators

  • Yvette I. Sheline, M.D. · Washington University Psychiatrist

  • Murali Doraiswamy, M.D. · Duke University

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-04-30
Primary Completion
2006-04-30
Completion
2006-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00045773 on ClinicalTrials.gov